imiquimod has been researched along with Eyelid Neoplasms in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 7 (31.82) | 29.6817 |
2010's | 15 (68.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ged, C; Hernández-Martín, A; Knöpfel, N; Latour, I; Taïeb, A; Torrelo, A | 1 |
Gupta, P; Kakkar, N; Singh, H; Singh, M; Zadeng, Z | 1 |
Bonilla, R; Jones, CA; Khandwala, MA; Solebo, AL | 1 |
Bratton, EM; Durairaj, VD; Gregory, DG; Knutsen-Larson, S; Mellette, JR | 1 |
Carneiro, RC; de Lima, PP; de Macedo, EM; Matayoshi, S; Silva, BG | 1 |
Álvarez-Coronado, M; Costales-Álvarez, C; Fernández-Vega, L; González-Rodríguez, CM; Rozas-Reyes, P | 1 |
Fazil, K; Karabulut, GO; Kaynak, P; Ocak, OB; Ozturker, C; Taskapılı, M | 1 |
Collins, C; Harrad, RA; Kennedy, CT; Ross, AH | 1 |
Bianciotto, CG; Demirci, H; Shields, CL; Shields, JA | 1 |
Alfaro, J; Fernandez, J; Garcia-Martin, E; Gil, LM; Idoipe, M; Pablo, LE; Pueyo, V; Zubiri, ML | 1 |
Prokosch, V; Spaniol, K; Stupp, T; Thanos, S | 1 |
Fernández Tirado, FJ; García Martín, E | 1 |
Alfaro, J; Fernandez, FJ; Garcia-Martin, E; Gil-Arribas, LM; Idoipe, M; Pablo, LE; Pueyo, V | 1 |
Bassukas, ID; Gaitanis, G; Kalogeropoulos, C | 1 |
Apalla, Z; Karteridou, A; Lallas, A; Lefaki, I; Sotiriou, E; Tzellos, T; Varytimiadis, D | 1 |
Anderson, HK; Brannan, PA; Kersten, RC; Kulwin, DR | 1 |
Balestrazzi, E; Blasi, MA; Giammaria, D | 1 |
Hollenbach, E; Huynh, NT; Tsang, HH | 1 |
Coscojuela-Santaliestra, C; Gilaberte-Calzada, Y; Martínez-Morales, J; Osán-Tello, M; Soler-Machín, J; Vera-Alvarez, J | 1 |
Busse, H; Choontanom, R; Stupp, T; Thanos, S | 1 |
Kaarniranta, K; Kontkanen, M; Leppälä, J; Uusitalo, H | 1 |
Bernardino, CR; Murchison, AP; Soloman, AR; Washington, CV | 1 |
2 trial(s) available for imiquimod and Eyelid Neoplasms
Article | Year |
---|---|
Imiquimod cream efficacy in the treatment of periocular nodular basal cell carcinoma: a non-randomized trial.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Neoplasm Recurrence, Local; Prospective Studies; Skin Cream; Treatment Outcome | 2015 |
Comparison of imiquimod 5% cream versus radiotherapy as treatment for eyelid basal cell carcinoma.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Remission Induction; Treatment Outcome | 2011 |
20 other study(ies) available for imiquimod and Eyelid Neoplasms
Article | Year |
---|---|
Reversed actinic damage in two children with xeroderma pigmentosum treated with topical imiquimod.
Topics: Administration, Cutaneous; Antineoplastic Agents; Carcinoma, Basal Cell; Child, Preschool; Eyelid Neoplasms; Humans; Imiquimod; Male; Nose Neoplasms; Skin Neoplasms; Xeroderma Pigmentosum | 2018 |
Treatment of squamous cell carcinoma of the eyelid with imiquimod 5% cream.
Topics: Administration, Topical; Aged, 80 and over; Antineoplastic Agents; Biopsy; Carcinoma, Squamous Cell; Eyelid Neoplasms; Humans; Imiquimod; Magnetic Resonance Imaging; Male; Skin Cream | 2019 |
Imiquimod 5% cream as an adjuvant pre-operative treatment for basal cell carcinoma of the periocular area.
Topics: Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Male; Middle Aged; Pilot Projects; Prospective Studies; Skin Cream; Skin Neoplasms | 2014 |
Combination topical therapy for conjunctival primary acquired melanosis with atypia and periocular lentigo maligna.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Conjunctival Diseases; Cryotherapy; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Interferon alpha-2; Interferon-alpha; Melanosis; Recombinant Proteins | 2015 |
Topical imiquimod 5% as an alternative therapy in periocular basal cell carcinoma in two patients with surgical contraindication.
Topics: Acquired Immunodeficiency Syndrome; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Contraindications, Procedure; Eyelid Neoplasms; HIV-Associated Lipodystrophy Syndrome; Humans; Imiquimod; Male; Middle Aged; Plastic Surgery Procedures; Remission Induction; Skin Ulcer; Surgical Flaps | 2017 |
Imiquimod 5% cream for the treatment of large nodular basal cell carcinoma at the medial canthal area.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Biopsy; Carcinoma, Basal Cell; Dose-Response Relationship, Drug; Eyelid Neoplasms; Female; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Neoplasm Staging; Ointments; Time Factors; Treatment Outcome | 2017 |
The use of imiquimod in the treatment of periocular tumours.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Keratosis, Actinic; Male; Middle Aged; Ophthalmic Solutions; Retrospective Studies; Skin Neoplasms; Treatment Outcome | 2010 |
Topical imiquimod for periocular lentigo maligna.
Topics: Adjuvants, Immunologic; Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Male; Middle Aged; Retrospective Studies; Skin Neoplasms | 2010 |
Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas.
Topics: Acrylic Resins; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Cryotherapy; Eyelid Neoplasms; Eyelids; Female; Humans; Imiquimod; Male; Middle Aged; Photochemotherapy; Skin Neoplasms; Treatment Outcome | 2010 |
Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Follow-Up Studies; Humans; Imiquimod; Male; Middle Aged; Prospective Studies; Skin Neoplasms; Treatment Outcome | 2011 |
[Periocular basal cell carcinoma treatment tendencies].
Topics: Aminolevulinic Acid; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Conjunctival Neoplasms; Eyelid Neoplasms; Humans; Imiquimod; Immunologic Factors; Mohs Surgery; Neoplasms, Radiation-Induced; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Sunlight | 2010 |
Imiquimod can be combined with cryosurgery (immunocryosurgery) for locally advanced periocular basal cell carcinomas.
Topics: Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Facial Neoplasms; Female; Humans; Imiquimod; Male; Nose Neoplasms | 2011 |
Letter: Immunocryotherapy for difficult-to-treat basal cell carcinoma of the eyelid.
Topics: Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Combined Modality Therapy; Cryosurgery; Eyelid Neoplasms; Humans; Imiquimod; Male; Middle Aged; Skin Neoplasms | 2013 |
Bowen disease of the eyelid successfully treated with imiquimod.
Topics: Administration, Topical; Aged; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Eyelid Neoplasms; Humans; Imiquimod; Male; Ointments; Skin Neoplasms | 2005 |
Immunotherapy with imiquimod 5% cream for eyelid nodular basal cell carcinoma.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Immunotherapy; Interferon Inducers; Male; Ointments; Treatment Outcome | 2005 |
Topical therapy with imiquimod for eyelid lesion.
Topics: Administration, Topical; Adult; Aminoquinolines; Antineoplastic Agents; Bowen's Disease; Eyelid Neoplasms; Humans; Imiquimod; Male; Skin Neoplasms | 2006 |
[Imiquimod in treatment of palpebral mycosis fungoides].
Topics: Adult; Aminoquinolines; Antineoplastic Agents; Eyelid Neoplasms; Eyelids; Humans; Imiquimod; Male; Mycosis Fungoides; Ophthalmologic Surgical Procedures; Skin Neoplasms; Treatment Outcome | 2006 |
Treatment of basal cell carcinoma of the eyelids with 5% topical imiquimod: a 3-year follow-up study.
Topics: Administration, Topical; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Humans; Imiquimod; Male; Middle Aged; Ointments; Treatment Outcome | 2007 |
Imiquimod in the treatment of eyelid basal cell carcinoma.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma, Basal Cell; Eyelid Neoplasms; Female; Humans; Imiquimod; Male; Ointments; Treatment Outcome | 2007 |
Ocular effects of imiquimod with treatment of eyelid melanoma in situ.
Topics: Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Conjunctiva; Erythema; Eyelid Neoplasms; Female; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Skin; Skin Neoplasms; Visual Acuity | 2007 |